Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Wednesday - 22 May 2024

Wednesday, 22 May 2024

Ceisteanna (158)

Pádraig O'Sullivan

Ceist:

158. Deputy Pádraig O'Sullivan asked the Minister for Health if he will provide specific information on the current status of the pricing and reimbursement application for dostarlimab (jemperli) indicated as monotherapy for the treatment of adult patients with recurrent or advanced endometrial cancer; and if he will make a statement on the matter. [23054/24]

Amharc ar fhreagra

Freagraí scríofa

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Barr
Roinn